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intracellular signaling events via Gβγ, leading to prolifera-
tion through the activation of p21ras (ras) and subsequent
activation of the p42 and p44 mitogen-activated protein
(MAP) kinases (Fig 1).4,5 PTx is a bacterial toxin that can
inhibit both Gαi and Gαo subunits by catalyzing the trans-
fer of an adenosine diphosphate (ADP) ribose moiety from
nicotinamide adenine dinucleotide to a cysteine residue at
the carboxyl terminus of the Gαi and Gαo proteins. The
concentration of PTx shown to induce 100% ADP ribosyla-
tion in vascular smooth muscle cells is 100 ng/mL.6 This
covalent modification and inactivation of Gαi and Gαo
abolishes receptor-mediated inhibition of adenylate cyclase
and is associated with increases in both basal and stimulated
cyclic adenosine monophosphate levels.3,7
In experimental vein grafts, there are changes in both
G-protein expression (αi, αo, αq, αs, and βγ subunits) and
G-protein function.6 Expression of Gαi2, Gαq, Gαs, and
Gβγ subunits was elevated, and de novo expression of Gαi3
was detectable by day 1. This Gαi3 expression continued to
increase through day 7, paralleling the development of inti-
mal hyperplasia.8 These alterations in G-protein subunit
expression were associated with a change in the functional
coupling of noradrenergic and serotonergic receptors to G-
proteins, with the vein grafts developing PTx-sensitive
responses to both agonists (the control jugular veins had a
PTx-insensitive response).6 Because PTx is an inhibitor of
Gαi/αo, the findings further suggest a role for the Gαi in
the development of intimal hyperplasia.
Little information exists about the expression of G-
During the development of intimal hyperplasia, there is
an alteration in the balance between medial smooth muscle
cell proliferation and apoptosis in the media. Thereafter,
there is medial smooth muscle cell migration into the
intima mediated by the matrix metalloproteinases (MMP 2
and MMP 9). Once within the intima, the newly migrated
cells proliferate, expanding the volume of the intima by lay-
ing down extracellular matrix.1 Guanine nucleotide binding
proteins (G-proteins) are crucial components of membrane
transduction mechanisms, to which many receptor-medi-
ated processes are coupled. With stimulation, G-proteins
dissociate to Gα and Gβγ subunits, both of which can initi-
ate cellular signaling events.2,3 Several G-protein coupled
mitogens acting primarily through pertussis toxin (PTx)-
sensitive G-proteins have been shown to specifically trigger
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Purpose: Guanine nucleotide binding protein (G-protein) coupled receptors are involved in smooth muscle cell prolifer-
ation, but the role of G-proteins in arterial intimal hyperplasia has not been defined. This study examines the expression
of G-proteins in the developing intimal hyperplasia after balloon injury of the rat carotid artery and specifically tests the
hypothesis that the pertussis toxin sensitive Gi G-protein subunit plays a role in the initiation of intimal hyperplasia.
Methods: In vitro responses to serum stimulation (10% fetal bovine serum) were examined in the presence and absence of
pertussis toxin (PTx). After a standard balloon injury in male Sprague-Dawley rats, the expression of G-protein subunits
(αo, αi, αq, αs, and βγ) was determined by means of Western blotting in the first 28 days. Thereafter, a second set of ani-
mals was allocated to control and PTx-treated (a Gαi inhibitor; 500 ng/mL in an externally applied 30% pluronic gel)
groups. Smooth muscle cell proliferation was estimated by means of thymidine analogue 5-bromo-2´ deoxyuridine incor-
poration 2 days after injury, and vessel dimensions were determined by means of videomorphometry 14 days after injury.
Results: There was inhibition of DNA synthesis and smooth muscle cell proliferation in response to serum with an IC50
of 100 ng/mL. Three days after balloon injury, there was an increase in Gαi3 expression, which decreased at days 7, 14,
and 28, compared with the uninjured carotid. Gαq expression increased in a time-dependent manner. There was a marked
time-dependent increase in Gβγ in the 28 days. Gαi2 and Gαs isoforms (45 and 52 kDa) did not change significantly
with time. There was no major change in Gαi1 and Gαo in the study period. At 14 days, PTx treatment reduced intimal
hyperplasia by 52% (63 ± 4 µm vs 30 ± 5 µm, control vs PTx; P < .001). Medial smooth muscle cell proliferation at day
2 was decreased in the PTx group, compared with that in the gel-coated group (15% ± 2% and 26% ± 3%; P = .02).
Conclusion: After balloon injury, there is a time-dependent increase in G-protein expression, which is subunit specific.
Activation of PTx sensitive G-proteins (Gαi) is involved during the initiation of intimal hyperplasia after arterial injury,
and their inhibition results in a decrease in early medial cell proliferation. This acute interruption of Gi signaling pro-
duces a long-term decrease in intimal hyperplasia. (J Vasc Surg 2001;33:408-18.)
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proteins during the development of intimal hyperplasia in
the arterial system. This study examines the role of PTx-
sensitive G-proteins in in vitro smooth muscle cell prolif-
eration and the time course of expression of G-proteins in
the developing intimal hyperplasia after balloon injury of
the rat carotid artery.
MATERIALS AND METHODS
Experimental design
The effect of inhibition of the G-proteins, Gαi/o, with
PTx (an inhibitor of the αi/o G-proteins by ADP ribosyla-
tion; Sigma, St Louis, Mo) on DNA synthesis, cell prolif-
eration, and cell migration of cultured rat vascular smooth
muscle cells was assessed in vitro. On the basis of these
data, male Sprague-Dawley rats (3-4 months old; weigh-
ing 300-350 mg; B & K Laboratories, Seattle, Wash)
underwent standard balloon injury of their common
carotid artery.9 The temporal expression of G-proteins in
the carotid artery after balloon injury was examined in 28
days and compared with that in uninjured controls.
Thereafter, the effect of local administration of the Gαi/o
inhibitor, PTx, on the development of intimal hyperplasia
in the balloon-injured carotid was tested. Animals were
randomly allocated to the injured, injured-carrier, and
injured-carrier-PTx (500 ng/mL; Sigma) groups preoper-
Fig 1. Transduction events by G-proteins. An orderly sequence of events occur on ligand binding to G-protein coupled receptor.
Coupling of the receptor to the Gαi/Gβγ complex allows dissociation of Gαι and Gβγ. Pertussis toxin (PTx) blocks receptor coupling
and complex disassociation. Gαi inhibits the activity of adenylyl cyclase, which in turn alters PKA activity. Through a series of secondary
pathways, altered PKA activity will lead to an increase in ras activation. Gβγ activates Ras/Raf-1/MEK1 to induce ERK activation. In
addition, Gβγ directly or through ras activation induces PI3K activation, which feeds backs to raf leading to ERK activation. ERK acti-
vation is associated with smooth muscle cell proliferation.
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atively. Pluronic gel (1 mL of 30% F127 pluronic gel;
Sigma) was applied to the external surface of the distal
carotid at the end of the procedure, as described earlier.10
The pluronic gel remains in a liquid form at 4°C and
rapidly forms a gel on exposure to body temperature.
Animals were killed with an overdose of barbiturates at
multiple time points after the operation (4 hours, 8 hours,
16 hours, 24 hours, 48 hours, 3 days, 4 days, 7 days, 14
days, and 28 days), and samples were harvested for protein
biochemistry (n = 4 per time point in each group), zymog-
raphy (n = 3 per time point in each group), immunocyto-
chemistry (n = 4 per time point in each group), and
morphology and planimetry (n = 10 per group). Animal
care and procedures were conducted at the University of
Washington Medical Center in accordance with state and
federal laws and under protocols approved by the
University of Washington Animal Care and Use
Committee. Animal care complied with the Guide for the
Care and Use of Laboratory Animals issued by the
Institute of Laboratory Animal Resources.11
Operative procedure
Anesthesia was induced with an intramuscular solution
(1.0 mL/kg) of ketamine hydrochloride (50 mg/mL;
Ketaset, Bristol Laboratories, Syracuse, NY), xylazine (5
mg/mL; Xylaject, Phoenix Pharmaceutical, St Joseph,
Minn), and acepromazine (1 mg/mL, Fermenta Animal
Health, Kansas City, Mo). Balloon injury of the left carotid
artery was performed by using the standard technique
described earlier.9 Under sterile conditions, a midline inci-
sion was made in the neck, and the bifurcation of the left
common carotid artery was dissected out and isolated. An
arteriotomy was made in the external carotid artery, and a
2F Fogarty balloon catheter (Baxter Healthcare, Irvine,
Calif) was introduced. The balloon was then inflated and
withdrawn while being rotated through 120 to 270
degrees. After three passes, the catheter was removed, and
the external carotid was ligated. Pluronic gel was applied to
the distal external surface of the common carotid at the
end of the procedure. The wound was closed, and the ani-
mal was allowed to recover before its return to the vivar-
ium. At each determined time point, animals were killed
with an overdose of sodium pentobarbital (160 mg/kg
body weight; Anthony Products, Arcadia, Calif). Carotids
were then removed and snap frozen for protein analysis or
were perfusion-fixed in situ with Ringer’s lactate followed
by 10% formaldehyde in phosphate-buffered saline (PBS)
at 100 mm Hg.
Morphometry
After perfusion fixation, each vessel was bisected; gel-
encased (distal carotid) and non–gel-encased (proximal
carotid) and central segments from each of these halves
were embedded in paraffin, and cross sections were cut.12
Standard morphometric measurements were performed on
histologic cross sections stained with hematoxylin/eosin
with a camera lucida linked to a computer-driven digitizing
pad and software (OPELCO, Washington, DC). The lumi-
nal, intimal, and medial areas of the distal section of each
vessel were determined. After a determination of the
dimensions of each vessel, a ratio of the intimal and medial
areas (intimal ratio = intimal area/[intimal + medial areas])
and a ratio of luminal diameter to cross-sectional wall thick-
ness (luminal index = luminal diameter/[cross-sectional
wall thickness]) were calculated. The number of nuclei per
mm2 was counted as a means of determining the nuclear
density of each layer. The total number of nuclei per section
was also calculated as a means of determining the nuclear
mass per section. Four-day balloon-injured arteries har-
vested by means of perfusion fixation were processed enface
and stained with hematoxylin alone. Each vessel was divided
into sextiles (beginning at the carotid bifurcation and
extending retrograde to the aorta). The number of smooth
muscle cell nuclei identified above the internal elastic lam-
ina in a minimum of 10 high-power fields (400×) were
counted for the second and fourth sextiles to determine the
number of smooth muscle cells that had migrated across the
internal elastic lamina. Each vessel acted as its own control,
and migration was expressed as a percentage of the proxi-
mal intrathoracic undissected vessel segment compared
with the distal dissected vessel segment of each carotid.
Determination of in vivo proliferation and apoptosis
Paraffin-embedded histological cross sections were
mounted on positively charged slides (Superfrost Plus,
Curtis Matheson, Houston, Tex). Immunohistochemical
procedures were performed according to the avidin-biotin-
peroxidase method (Vector Laboratories, Burlingame,
Calif). Sections were deparaffinized in xylene, rehydrated
in graded alcohols, and equilibrated in PBS. Blocking
solution (10% horse serum in PBS) was applied for 1 hour
at room temperature. Incubation with the primary anti-
bodies was followed by sequential incubation with
biotinylated antimouse IgG and ABC reagent, according
to the manufacturer’s specifications (Vectastain ABC kit,
Vector Laboratories). Murine IgG was used as a negative
control for all experiments. Levamisole was added to block
endogenous alkaline phosphatase activity, and immune
complexes were localized with the chromogenic alkaline
phosphatase substrate Vector Red (Vector Laboratories).
Labeling of proliferating smooth muscle cells in carotid
specimens was evaluated with the thymidine analogue 5-
bromo-2´ deoxyuridine (BrdU; Boehringer-Mannheim,
Indianapolis, Ind; administered by subcutaneous pellet
implantation 24 hours before killing) at 1 and 2 days after
balloon injury. The number of BrdU-stained smooth mus-
cle cell nuclei were counted, and the BrdU labeling index
(percent of unlabelled cells) was calculated. Labeling of
apoptotic smooth muscle cells on adjacent sections from
the same carotid specimens were evaluated with terminal
deoxynucleotidyl transferase-mediated dUTP-biotin nick
end labeling (TUNEL; Boehringer-Mannheim) after pro-
cessing the tissue according to the manufacturer’s guide-
lines. Stained smooth muscle cell nuclei were counted, and
the TUNEL labeling index (percent of unlabeled cells)
was calculated.
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Immunoblotting
After balloon injury, carotids were rapidly retrieved,
cleaned, and washed in 30 mL of ice-cold PBS buffer before
being frozen in liquid nitrogen and stored at –80°C. The
frozen tissue was then pulverized and placed in 250 µL of
buffer HEB (25 mmol/L Hepes, pH = 7.5, 10% glycerol, 5
mmol/L EDTA, 5 mmol/L EGTA, 150 mmol/L NaCl 1
mmol/L benzamidine, 0.1% 2-mercaptoethanol, 1% Triton
X-100, 1 µmol/L pepstatin A, 2 µg/mL leupeptin, and 20
kallikrein inhibitor units/mL aprotinin). The suspension was
sonicated with a medical sciences equipment apparatus
(Pittsburgh, Pa) while it was kept on ice for 4 × 10 seconds
and centrifuged at 3000 rpm at 4°C. The supernatant was
then collected. Protein determinations were performed with
bovine serum albumen as the standard (Pierce Chemical,
Rockford, Ill). Equal amounts of protein (75 µg) were loaded
onto a 10% polyacrylamide gel separated by electrophoresis
and then transferred to a nitrocellulose membrane (Biorad
Laboratories, Richmond, Calif).13 The membrane was
blocked in 5% nonfat milk. The blot was then immunostained
with antibodies against Gαi, Gαo, Gαq, Gαs, and Gβγ sub-
units (1:1000; Calbiochem, LaJolla, Calif). Protein bands
were visualized by using an anti-mouse IgG horseradish per-
oxidase-conjugated antibody followed by Enhanced
ChemiLuminescence (ECL, Amersham, Arlington Heights,
Ill). Bands were quantified by means of scanning of radi-
ographs with an HP3C Deskscan (Hewlett-Packard) and ana-
lyzed with NIH ImageQuant software. The integrated
volume of each blot was expressed as a percentage of the vol-
ume of the uninjured common carotid band in the blot.
In vitro DNA synthesis and cell proliferation
Vascular smooth muscle cells from the media of the
aorta of male rats were isolated and grown in tissue cul-
ture. Quiescent smooth muscle cells in the sixth through
ninth passages were used for these experiments.
[H3]-thymidine incorporation. The experiments
were initiated by adding [H3]-thymidine (1 µCi/mL;
ICN, Irvine, Calif) with and without PTx (25, 50, 100,
and 200 ng/mL) and stimulating the cell with serum
(10% fetal bovine serum [FBS]). Incorporation of [H3]-
thymidine into acid-precipitable material was measured
after a 24-hour incubation period (air plus 5% CO2 at
37°C), as described earlier. Stimulation was expressed as
fold increase over starved cells (Dulbecco minimal essen-
tial medium [DMEM] only), and the effects of PTx were
expressed as a percentage of the stimulated control.
Cell proliferation. Cell proliferation in response to
serum (10% FBS) was assessed in the absence of and in the
presence of two concentrations of PTx (50 and 100
ng/mL). Cell counts were determined on days 1, 3, and
5. Cells from each well were removed by means of
trypsinization, and the resultant suspension was counted
with a Coulter counter. Duplicate cell counts were aver-
aged for each experimental group for each day.
In vitro migration assay
Smooth muscle cell migration was assayed by means of
a Boyden Chamber method with a 48-well microchemotaxis
chamber (Neuro Probe, Cabin John, Md) and polycarbon-
ate filters (Poretics Products, Livermore, Calif) with 10-µm
diameter pores, as described earlier.14,15 The filter was pre-
coated with basement membrane gel matrix (Matrigel;
Collaborative Biomedical Products, Becton Dickinson
Labware, Bedford, Mass) by floating the filter overnight in a
solution of DMEM and diluted matrigel (130 µg/mL in
0.5× PBS) at a volume ratio of 3 to 2. Platelet-derived
growth factor–BB (PDGF-BB) (10 ng/mL; 45 µL) was
placed in the lower compartment. Increasing concentrations
of PTx (10, 50, 100, and 200 ng/mL) were applied to the
upper compartment with the cells. The chamber was incu-
bated at 37°C under 5% CO2 for 5.5 hours. The top portion
of the filter was mechanically scraped, and smooth muscle
cells that had migrated to the bottom side of the filter were
fixed in a 100% solution of methanol, stained with Diff-
Quick staining solution (Dade International, Miami, Fla),
and counted at 400× magnification to quantitate smooth
muscle cell migration. Migration was determined as the
mean of cells that had migrated per 400× field and expressed
as a percentage of DMEM control. All experiments were
performed in triplicate.
In vivo protease activity
For in vivo assay of MMP2 and MMP9 activity, rat
carotid arteries were harvested at 0, 4, 8, 16, and 24 hours
after balloon injury. The injured segments were isolated and
snap frozen after rinsing in ice cold PBS. Segments were then
pulverized on liquid nitrogen by using a mortar and pestle
and extracted with a guanidine-based buffer (0.05 mol/L
TRIS, pH = 7.5, 0.01 mol/L CaCl2, 2.0 mol/L Guanidine,
and 0.2% Triton X-100). The suspension was centrifuged and
dialyzed against 0.05 mol/L TRIS and 0.2% Triton for 48
hours. A protein assay (Pierce, Rockford, Ill) was performed,
and 10 µg protein was loaded per lane. Gelatin zymography
for matrix metalloproteinases (MMPs) was performed as
described earlier.16 MMP2 and MMP9, purified as com-
plexes of tissue inhibitor of metalloproteinases 2 and 1,
respectively, were used as standards (a gift from H. G.
Welgus, Washington University, St Louis, Mo). Bands repre-
senting the intact zymogens (as defined by the standards)
were quantified by means of scanning of gels with an HP3C
Deskscan (Hewlett-Packard) and analyzed with ImageQuant
software (Molecular Dynamics, Sunnyvale, Calif).
Data and statistical analysis
All data are presented as the mean ± SEM, and statisti-
cal differences between groups were tested with a Kruskal-
Wallis nonparametric test with the post hoc Dunn multiple
comparison correction, when appropriate. A P value less
than .05 was regarded as significant. Nonsignificant P val-
ues were expressed as P = ns.
RESULTS
DNA synthesis, cell proliferation, and migration.
Proliferation and migration are two major acute responses
of smooth muscle cells after injury. We tested the role of
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Fig 2. A, The in vitro [3H]-thymidine incorporation into the DNA of cultured rat vascular smooth muscle cells in response to serum
(10% FCS) for the control and increasing concentrations of PTx. Stimulation with serum produced 6.1-fold increases in DNA synthe-
sis, compared with that of unstimulated cells. There is a concentration-dependent decrease in serum-mediated DNA synthesis with IC50
of 100 ng/mL, respectively. Values are the mean ± SEM percent of the control for 3 experiments. B, The inhibition of the in vitro pro-
liferation of cultured rat vascular smooth muscle cells by PTx after stimulation with serum (10% FCS). Values are the mean ± SEM of
cell counts (× 103) per milliliter for three experiments with DMEM (), serum (), and PTx: 50 ng/mL (), 100 ng/mL (). Analysis
by means of Kruskal-Wallis nonparametric test with post hoc Dunn multiple comparison correction. There is a significant difference 
(P < .01) in the cell counts in the presence of 100 ng/mL after serum stimulation. C, The concentration-dependent inhibition of the
in vitro cell migration of cultured rat vascular smooth muscle cells by PTx (25, 50, 100, 200 ng/mL) with the Boyden chamber method.
Values are the mean ± SEM of cell counts (×103) per milliliter for three experiments in response to PDGF-BB (10 ng/mL). P = .002
by means of Kruskal-Wallis nonparametric test with post hoc Dunn multiple comparison correction, when appropriate (*P < .05).
A
C
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PTx on in vitro cell proliferation and migration. As a
means of assessing the role of Gαi in cell proliferation, cul-
tured rat vascular smooth muscle cells were stimulated
with serum (10% FCS). Serum stimulation of cultured rat
smooth muscle cells starved for 48 hours resulted in a 6.1-
fold increase in DNA synthesis, compared with that of
unstimulated cells. In the presence of PTx, there was a
concentration-dependent decrease in serum-mediated
DNA synthesis with IC50 of 100 ng/mL (Fig 2, A). As a
means of examining the effect on cell proliferation, cells
were stimulated with serum (10% FCS), and samples were
counted from day 0 to day 5. In the presence of PTx (50
ng/mL), there was no effect on cell proliferation, whereas
incubation with PTx (100 ng/mL) prevented serum-stim-
ulated cell proliferation (Fig 2, B). As a means of assessing
the role of G-proteins in cell migration, smooth muscle
cells were placed in one compartment of a Boyden cham-
ber and exposed to the chemoattractant PDGF-BB in the
presence and absence of PTx. The presence of increasing
concentrations of PTx inhibited smooth muscle cell
migration through a thin matrigel membrane in a concen-
tration-dependent manner (Fig 2, C).
In vivo time course of G-protein expression. After
balloon injury, there was a time-dependent change in G-
protein expression. There was an increase in Gαi3 expres-
sion at 3 days, which decreased at day 7, 14, and 28,
compared with that of the uninjured carotid (Fig 2). Gαq
expression increased in a time-dependent manner (Fig 3).
There was a marked time-dependent increase in Gβγ (Fig
2). There was no major change in Gαi1 and Gαo during
the study period; similarly, Gαi2 and Gαs isoforms (45 and
52 kDa) did not change significantly (Fig 3).
Initial in vivo effects of Gαi inhibition by pertus-
sis toxin. To determine the contribution of Gαi proteins,
we administered PTx, a Gαi inhibitor (500 ng/mL
IC50x5), in a pluronic gel immediately after injury. This
Fig 3. The time course of G-protein expression in balloon-injured carotids in the first 14 days. A, Representative Western blots are
shown, and B, numerical data are displayed. Values are the mean ± SEM fold increase over signal in the uninjured common carotid. All
G-protein subunits studied were detectable in the control, uninjured carotid. Analysis by means of Kruskal-Wallis nonparametric test
with post hoc Dunn multiple comparison correction, when appropriate (*P < .05).
A
B
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gel is only present for as long as 8 hours after application
and delivers variable concentrations of the drug to the
media and adventitia of the vessel. After balloon injury,
smooth muscle cell proliferation in the media at day 2 was
decreased significantly in the PTx group, compared with
that in the gel-treated group (26% ± 3% and 15% ± 2%; P
= .02). Medial smooth muscle cell apoptosis as assayed by
means of TUNEL staining was equivalent at day 1 (36% ±
1% vs 37% ± 2%, PTx vs control; P = ns) and at day 2 (35%
± 2% vs 38% ± 2%; PTx vs control; P = ns), suggesting the
absence of significant cytotoxic effects. Because of the
alterations in migration by PTx in vitro, MMP activity of
balloon-injured carotids in the presence and absence of
PTx was examined. MMP 2 and MMP 9 activity of bal-
loon-injured carotids as determined by means of gel
zymography was increased at 4 hours after injury and
decreased slowly at 8, 16, and 24 hours after balloon
injury (Fig 4). Exposure to PTx did not affect the early
zymogen activation (MMP 2 and MMP 9), but did accel-
erate the decay of activity with time. In the presence of
PTx, there was a 40% increase in MMP 2 activity at 4
hours after injury, compared with that of untreated con-
trols (P = ns); thereafter, there was a decrease in MMP 2
activity at 8 hours (53% decrease compared with untreated
corresponding controls; P = ns), 16 hours (80% decrease;
P < .05), and 24 hours (71% decrease; P < .05) after injury
(Fig 4). In the PTx-treated arteries, MMP 9 activity
decreased only 9% in activity at 4 hours, compared with
that of untreated controls (P = ns), with a sustained
decrease in activity at 8 hours (71% decrease; P < .05), 16
Fig 4. Gel zymography of protein extracted from balloon-injured carotids in the first 24 hours in the presence () and absence () of
PTx. Bar charts for activated intact forms of MMP-2 and MMP-9 are shown in A and B, respectively. Values are the mean ± SEM per-
cent of control for three experiments. Analysis by means of Kruskal-Wallis nonparametric test with post hoc Dunn multiple comparison
correction, when appropriate (*P < .05).
A
B
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Fig 5. A, A composite photomicrograph that shows a cross section from the wall of control, gel-encased, and PTx-treated carotids 14
days after balloon injury. Arrows indicate the internal elastic lamina (original magnification, 100×). B, Mean intimal and medial thick-
ness of the wall of control, gel-encased, and PTx-treated carotids 14 days after balloon injury. Values are mean thickness in microns.
Analysis by means of Kruskal-Wallis nonparametric test with post hoc Dunn multiple comparison correction, when appropriate (*P <
.001). C, Nuclear density of the wall of control, gel-encased, and PTx-treated carotids 14 days after balloon injury. Values are the mean
nuclei per square millimeter. Analysis by means of Kruskal-Wallis nonparametric test with post hoc Dunn multiple comparison correc-
tion, when appropriate (*P < .01). IH, intimal hyperplasia.
B
C
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hours (42% decrease; P < .05), and 24 hours (76%
decrease; P < .05) after injury (Fig 4). In vivo smooth
muscle cell migration counted at day 4 was not signifi-
cantly different between the 3 groups (130% ± 15%, 90%
± 21%, and 81% ± 15% for control, gel-treated, and PTx-
treated arteries, respectively; percent proximal arterial
counts; P = ns).
Effects of Gαi inhibition by pertussis toxin at 14
days. Application of gel to the external surface of the
carotid produced a 19% increase in the intimal thickness
(63 ± 4 µm vs 50 ± 3 µm; P = ns) and a 6% increase in the
medial thickness (51 ± 3 µm vs 48 ± 9 µm; P = ns), com-
pared with that of untreated controls. Local application of
PTx produced a significant decrease (52%) in the intimal
thickness (30 ± 5 µm; P < .001) without a significant
change in medial thickness (59 ± 4 µm; P = ns), compared
with that of gel-coated controls (Fig 5, A and B). The inti-
mal ratio of the PTx-treated carotids decreased by 52%,
compared with that of the gel-coated controls (P < .001;
Table). There was only an 8% increase in overall luminal
area of the PTx-treated vessels, compared with that of the
gel-coated controls (P = ns; Table). The circumferences of
the internal elastic lamina and external elastic lamina were
unchanged across the groups (Table). The luminal index,
a measure of remodeling based on changes in luminal
diameter in relation to total wall thickness, increased by
75% with PTx therapy (P < .01; Table), reflecting an
unchanged lumen supported by a thinner wall. However,
this luminal index is only 51% of the uninjured carotid (P
< .01; Table). Associated with the reduction in intimal
hyperplasia at 14 days in PTx-treated vessels, there was a
17% decrease in intimal nuclear density (11.2 ± 0.6 vs 8.6
± 0.3 × 103 nuclei/mm2, gel vs PTx; P < .05) without a
significant change (–4%) in medial nuclear density (4.1 ±
0.4 vs 3.9 ± 0.3 × 103 nuclei/mm2; P = ns). The intimal
nuclear density combined with the intimal area translated
into a significant decrease in the total number of nuclei per
section in the PTx-treated group (1821 ± 345 vs 478 ± 92
nuclei/section, gel vs PTx; P < .01).
DISCUSSION
For a vessel to respond to injury, there must be an
alteration in the balance between medial smooth muscle
cell proliferation and apoptosis, medial smooth muscle cell
migration into the intima, proliferation of intimal smooth
muscle cell, intimal expansion with extracellular matrix syn-
thesized by smooth muscle cells, and finally, intimal
remodeling.1,17 The current results demonstrate that there
are time-dependent changes in G-protein expression after
balloon injury, specifically with Gαi3 expression increasing
at 3 days and both Gαq and Gβγ expression increasing in a
time-dependent manner in the 28 days. A role for the Gαi
was implied by the Gαi inhibitor PTx in vitro and in vivo.
It has previously been shown that intimal hyperplastic vein
grafts harvested at 28 days postoperatively have increased
expression of G-proteins (GαS, Gαi2, and Gβγ subunits)
and de novo expression of Gαi3. In addition, receptor cou-
pled responses change from being PTx insensitive in the
jugular vein to being PTx sensitive in the vein graft.6
Several inhibitor studies have strengthened the contention
that G-proteins are involved in the genesis of intimal
hyperplasia.18-21
In the current study, we show that there were signifi-
cant early increases in Gαi3, Gαq, and Gβγ subunits. These
increases in expression coincided with the period of medial
smooth muscle cell mitogenesis in this model. The pattern
is similar to that seen in vein grafts for Gαi3, Gαq, and
Gβγ, but not for the GαS subunits. Gi-coupled receptors
activated by ligands, such as LPA, α2-adrenergic, and M2
muscarinic, activate the ras-MAP kinase pathway through
Gαi/Gβγ, whereas Gαs and Gαq-coupled receptors do
not.4,22 Other agents that can couple and activate Gαi
Dimensional analysis
Control (n = 10) Gel (n = 10) PTx (n = 10) P value
Cross-sectional area
Luminal area (mm2) 0.24 ± 0.02 0.24 ± 0.03 0.26 ± 0.02 NS
Intima (mm2) 0.12 ± 0.01 0.11 ± 0.01 0.06 ± 0.01*† .0001
Media (mm2) 0.11 ± 0.01 0.16 ± 0.02 0.13 ± 0.01 NS
IEL (mm) 2.11 ± 0.05 2.22 ± 0.10 1.99 ± 0.05 NS
EEL (mm) 2.42 ± 0.05 2.54 ± 0.10 2.46 ± 0.06 NS
Intimal ratio 0.51 ± 0.02 0.56 ± 0.03 0.27 ± 0.04*† .0001
Luminal index 5.34 ± 0.35 4.19 ± 0.50 7.33 ± 0.88‡ .009
Nuclear density
Intima (103/mm2) 10.81 ± 0.62 11.18 ± 0.56 8.6 ± 0.34§ .02
Media (103/mm2) 3.96 ± 0.22 4.07 ± 0.44 3.9 ± 0.32 NS
The areas of the lumen and the intimal and the medial layers from the control, gel encased, and pertussis toxin (PTX) treated-carotids, 14 days after bal-
loon injury. The intima ratio (intimal area/[intimal + medial areas]) and luminal index (luminal diameter/[cross-sectional wall thickness]) are shown (the
luminal index of an uninjured carotid artery is 15.06 ± 0.96). The circumference of the IEL and the EEL are shown (IEL and EEL of the uninjured carotid
were 2.17 ± 0.03 mm and 2.47 ± 0.04 mm, respectively). Nuclear density on the intima and media are also shown (density in the media of an uninjured
carotid was 3.62 ± 0.42 × 103/mm2). Values are the mean ± SEM. Statistical differences between these groups of data were tested by means of Kruskal-
Wallis nonparametric analysis of variance with post hoc Dunn multiple comparison test, when appropriate.
*P < .001, control vs PTx.
†P < .001, gel vs PTx. 
‡P < .01, gel vs PTx.
§P < .05, gel vs PTx.
IEL, Internal elastic lamina; EEL, external elastic lamina.
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include thrombin and angiotensin II (both, however, can
also couple to Gαq). The presence of Gαq appears to be
important for PDGF-induced mitogenesis, because
increases in its expression potentiate PDGF-induced mito-
genesis in fibroblasts.23 It was suggested by means of the
in vitro DNA synthesis and proliferative data in the cur-
rent study that PTx can inhibit smooth muscle cell mito-
genesis in response to serum. Similar results have been
seen in guinea pig aortic smooth muscle cells, with a 70%
to 100% decrease in cell growth without cell death as long
as 10 days.24 Interestingly, these authors demonstrated
that the growth inhibition was independent of any
increase in cyclic adenosine monophosphate concentra-
tions and could not be overcome by the addition of
PDGF.24 The treatment of the arteries with PTx resulted
in a significant decrease in smooth muscle cell prolifera-
tion at day 2 in this study.
Cell proliferation may be a natural response to cell
injury and death induced by the balloon injury. Significant
smooth muscle cell apoptosis was identified at day 1 (36% ±
1%) and at day 2 (38% ± 2%). Smooth muscle cell injury
caused by mechanical forces can be detected after balloon
injury of the rat carotid at 1 to 2 hours and has been shown
to disappear by 4 hours.25 Although high levels of medial
cell apoptosis were present in the wall of the injured carotid
at both day 1 and day 2 in this study, these levels of apop-
tosis were unchanged by the presence of PTx, suggesting
no direct cell toxicity of the dose applied. Specific blockade
of the Gβγ-subunit in balloon-injured carotids with a single
exposure to the Gβγ inhibitor βARKCT also reduces intimal
hyperplasia.21 These findings suggest that PTx-sensitive Gαi
and Gβγ are involved in the smooth muscle cellular prolif-
eration required for intimal hyperplasia formation. How-
ever, this phase is considered to be driven predominantly by
basic fibroblast growth factor (bFGF) in the rat, and in vitro
PTx does not affect bFGF signaling.1,26-28 The mechanism
of action may be caused by inhibition of Gαi’s release of
Gβγ and the subsequent blockade of MAPK activation. In
vitro studies would support this supposition.21
Migration of the smooth muscle cells toward the
intima in the rat carotid is mediated, in part, by PDGF.29
The matrix metalloproteinases (MMP 2 and MMP 9)
appear to be involved in smooth muscle cell migration
induced by PDGF-BB.30,31 In the present study, we have
shown that there is a concentration-dependent inhibition
of migration toward the chemoattractant PDGF-BB.
Although many small G-proteins are necessary for PDGF-
BB mediated mitogenesis and migration,32,33 there are no
data that the blockade of PTx-sensitive pathways plays a
role in PDGF-mediated migration. However, there are
data to support the suggestion that there is a PTx-sensitive
component to PDGF-mediated mitogenesis, which has not
yet been defined.24 Chemotaxis has been shown to be
mediated by activation of Gαi, but not Gαq or Gαs in a
transfected lymphocyte cell line. Furthermore, although
PTx has no effect on chemotaxis to fibronectin, collagen I,
and collagen IV, it will partially inhibit haptotaxis (directed
cellular migration toward an insoluble factor) and will
eliminate chemotaxis (directed cellular migration toward a
soluble factor) to laminin.34 The role of G-proteins in
PDGF-mediated chemotaxis remains to be resolved.
Within hours of balloon injury in carotids, MMP 9
(gelatinase B) is activated and remains active for the first 7
days.35 There are also increases in metalloproteinase MMP
2 (gelatinase A) at 1, 2, and 4 weeks after injury.36 We did
demonstrate an unaltered increase in MMP 2 and MMP 9
activity, followed by significant suppression of activity after
injury in the presence of PTx, suggesting that in vivo PTx
did modulate MMP activity. This early depression in MMP
activation was associated with a subsequent decrease in cell
proliferation at day 2, but had no effect at day 4, as deter-
mined by means of in vivo migration. The results suggest a
role for G-protein coupled pathways in the regulation of the
sustained pattern of MMP activation after an initial PTx-
independent activation pathway. The findings of a marked
reduction in those enzymes, which are capable of altering
the extracellular matrix around an individual smooth mus-
cle cell, is of interest. Smooth muscle cell proliferation is, in
part, controlled by the presence of either growth-permissive
or growth-inhibitory extracellular matrices. The current
study shows an association of a decreased smooth muscle
cell proliferation in vivo, with a change in overall MMP
activity when the vessel is treated with PTx, and may point
to an additional mechanism, by which PTx can decrease the
smooth muscle cell response to injury.
The pluronic gel delivery system used in the current
study is very transient, and we admit that it delivers the
PTx at an unknown concentration to the media and
adventitial surface of the vessel. We chose five times the
IC50 of PTx as a working dose. It is unlikely that we had
direct toxicity, because there was no cell death induced in
vitro until 200 ng/mL was reached and no change in
apoptosis in vivo. We did note a decrease in intimal but
not medial nuclear density in the PTx-treated animals.
This may have arisen for several reasons: (1) PTx inhibited
Gαi activation and its related pathways; (2) PTx inhibited
Gαi release of Gβγ with the subsequent blockade of
MAPK activation; (3) PTx induced an alteration in sus-
tained MMP activation; or (4) PTx had a poorly defined
effect on PDGF signaling.
In conclusion, activation of PTx-sensitive G-proteins
(Gαi) are required for the initiation of intimal hyperpla-
sia after arterial injury, and inhibition of this activation
with periadventitial PTx results in a decrease in early cell
proliferation. Which agonists and which G-protein cou-
pled receptors are involved remain to be defined. It also
remains to be defined whether Gαi is the prime media-
tor or the Gβγ subunit associated with the Gαi or a com-
bination of both subunits. In light of our findings, the
role of activated PTx-sensitive G-protein coupled recep-
tors in the development of intimal hyperplasia must be
further defined.
We thank Holly Lea, Monika Clowes, and Richard
Kenagy (University of Washington) for their assistance
and advice.
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